Dr. Ann Childress, principal investigator on Cingulate’s CTx-1301 trials, highlights some of the differences in ADHD symptoms between children and adults.
#ADHD #Neuroscience #Biotech #SmallCapBiotech #BiotechInvesting #ClinicalPipeline #DrugDevelopment #NASDAQ